Psy187 - The Quantity and Quality of Evidence Supporting European Marketing Authorisation of Orphan Drugs: Comparison of Rare Oncology Versus Rare Disease

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2761